Psychosocial Support for Cancer Patients
April 19, 2011 updated by: Memorial Sloan Kettering Cancer Center
This is an international, 3-site trial (Winnipeg Canada, MSKCC NYC, Perth Australia) accruing 120 patients per site (120x3).
The purpose of this study is to compare two types of counseling for cancer patients: "Dignity Psychotherapy" and "Supportive Psychotherapy" as well as "Standard Palliative Care."
Many cancer patients seek counseling to help with the emotional burden of their illnesses.
Counseling often helps them cope with cancer by giving them a place to express their feelings.
We, the investigators at Memorial Sloan-Kettering Cancer Center, have developed a type of counseling we call "Dignity Psychotherapy."
It is intended to help cancer patients maintain or enhance a sense of purpose, meaning, and overall quality of life, despite having cancer.
"Supportive Psychotherapy" is another type of counseling intended to help patients feel more at ease and express and reflect on any feelings or concerns they might have about their illness.
Both of these types of counseling will be compared to "Standard Palliative Care."
We will look at how these types of treatments affect patients' mood, outlook, and quality of life.
We also want to see how the type of treatment they receive affects their family members and significant others.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Primary Objective:
- To establish the efficacy of a new and unique individual, brief intervention we call "Dignity Psychotherapy" in enhancing a sense of meaning, purpose and overall well-being for patients with advanced, end stage cancer.
Secondary Objectives:
- To compare the effectiveness of "Dignity Psychotherapy" with "Supportive Psychotherapy" and "Standard Palliative Care" in bolstering the patients' sense of meaning, purpose, generativity, and overall sense of dignity and quality of life, while lessening hopelessness, sense of being a burden to others, and suffering.
- To explore the impact "Dignity Psychotherapy" has on the bereavement experience of those family members/significant others taking part in this arm of the study protocol.
- To compare the bereavement experience of bereaved family members/significant others whose loved ones took part in any one of the three study conditions.
Study Type
Observational
Enrollment (Actual)
281
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Memorial Sloan-Kettering Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients will be recruited from the Pain and Palliative Care Service and Gastrointestinal Service of the Memorial Sloan Kettering Cancer Center.
Description
Inclusion Criteria:
- The patient must be at least 18 years of age (because of the nature of "Dignity Psychotherapy," which presumes a relatively advanced level of social and psychological development).
- Have a terminal illness (Stage IV with a prognosis of less than 6 months, but expected to live at least 7 to 10 days, i.e. the average length of the protocol)
- Must be able to identify a family member/significant other who agrees to participate in the study (in the case of "Dignity Psychotherapy," this family member/significant other will receive the generativity document)
- Be able to communicate with an English-speaking therapist (patients who are visually impaired will be offered assistance with the consent forms and surveys)
- In the investigator's judgement, participant is cognitively able to provide valid, informed consent.
Exclusion Criteria:
- Significant psychiatric disturbance sufficient to preclude participation in a psychotherapeutic intervention (e.g. acute, severe psychiatric symptoms which would require individual treatment and medication management rather than a psychotherapy intervention).
- Active psychotic mental disorder (e.g. schizophrenia, acute mania), or marked paranoid ideation. Patients who are on stable regimens of psychotropic medications (e.g. antidepressants for clinical depression) or who are in concurrent individual or group psychotherapy will not be excluded. This information regarding concurrent psychiatric treatment will be collected and utilized as a co-variate in data analysis.
- Presence of a cognitive disturbance (i.e. delirium or dementia) sufficient to preclude participation in psychotherapy, and/or data collection.
- Physical limitations or illness severity sufficient to preclude participation in psychotherapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1
Dignity Psychotherapy
|
At the beginning and at the end of the study, you will be asked to fill out a series of questionnaires.will
also receive three visits by a mental health professional over a period of five to seven days.
You will be asked to fill out some brief questionnaires during this session which ask about feelings about your illness, symptoms, emotional reactions, and support you have available.
The second meeting will be scheduled as soon as you are able to do so, within no more than 24 to 48 hours from your initial session with the Research Staff.The third meeting you will also be asked to fill out several questionnaires,including a specific questionnaire regarding your thoughts about the Dignity Psychotherapy Intervention.
Total time commitment for this study should be approximately 120-150 minutes.
|
|
2
Supportive Psychotherapy
|
you will receive the standard care you normally would receive, but will also receive three visits by a mental health professional over a period of five to seven days.
The initial visit will take approximately 45 minutes.
You will be asked to fill out brief questionnaires (described above) during this session.A second contact will be scheduled as soon as you are able to do so, within no more than 24 to 48 hours from your initial session with the research staff.
During this second session, you will have the opportunity to discuss with a supportive research therapist issues or topics relevant to your experience of coping with cancer.The third and final contact,you will be asked you to fill out questionnaires similar to those you filled out at the beginning of the study.
Total time commitment for this study should be approximately 120-150 minutes.
|
|
3
Standard Palliative Care
|
If you are in the "Standard Palliative Care" group you will receive the standard care that is usually provided here at Memorial Hospital.
This can include services such as consultations by physicians, nurses and other healthcare professionals.
In addition, referrals to community resources and services can also be made.
The study period will be between five and seven days.
At the beginning and at the end of the study, you will be asked to fill out a series of questionnaires as described above.
Total time commitment for this study should be approximately 60-90 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To establish the efficacy of a new and unique individual, brief intervention called "Dignity Psychotherapy" in enhancing a sense of meaning, purpose and overall well-being for patients with advanced, end stage cancer
Time Frame: 7-10 days
|
7-10 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To compare the effectiveness of "Dignity Psychotherapy" with "Supportive Psychotherapy" and "Standard Palliative Care" in bolstering the patients' sense of meaning
Time Frame: 7-10 days
|
7-10 days
|
|
To explore the impact "Dignity Psychotherapy" has on the bereavement experience of those family members/significant others taking part in this arm of the study protocol
Time Frame: 7-10 days
|
7-10 days
|
|
To compare the bereavement experience of bereaved family members/significant others whose loved ones took part in any one of the three study conditions
Time Frame: Six to nine months following the death of the patient
|
Six to nine months following the death of the patient
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: William Breitbart, MD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2005
Primary Completion (Actual)
April 1, 2011
Study Completion (Actual)
April 1, 2011
Study Registration Dates
First Submitted
August 23, 2005
First Submitted That Met QC Criteria
August 23, 2005
First Posted (Estimate)
August 24, 2005
Study Record Updates
Last Update Posted (Estimate)
April 20, 2011
Last Update Submitted That Met QC Criteria
April 19, 2011
Last Verified
April 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- 05-042
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.